Top Markets
Coin of the day
Yubo International Biotech Limited Yubo International Biotech Limited

Yubo International Biotech Limited

YBGJ
Rank in Stocks #38245
Yubo International Biotech Limited, operating through its various subsidiaries,... Yubo International Biotech Limited, operating through its various subsidiaries, primarily dedicates its efforts to the research, development, and practical application of endometrial stem cells. Beyond this core focus, the company also provides a diverse range of products, including solutions for respiratory health, skincare and hair care formulations, nutritious beverages, and personal care items tailored for both men and women. Furthermore, it delivers specialized stem cell services, such as cellular analysis and comprehensive health management consulting, all offered under the VIVCELL brand. The company's headquarters are located in Beijing, China.
Share Price
$0.0065
Market Cap
$1.11M
Change (1 day)
-45.38%
Change (1 year)
-80.03%
Country
CN
Trade Yubo International Biotech Limited (YBGJ)

Category

Operating Margin for Yubo International Biotech Limited (YBGJ)
Operating Margin as of 2026 TTM: 0.00%
According to Yubo International Biotech Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Yubo International Biotech Limited from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
31.28% -
US
12.36% -
FR
0.00% -
JP
10.61% -
US
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.